Do you need a UK Responsible Person to meet your UK regulatory requirements? If you do – or even if you aren’t sure if you do, IMed can help. Post Brexit, medical device manufacturers based outside the UK, selling or wishing to sell their products in the UK – will need to appoint a UK…
Loughborough’s life sciences hub Charnwood Campus has recommissioned its world-class synthetic and chemistry research facility to the highest standard to cater to the needs of its newest occupier and leading pre-clinical discovery contract research organisation (CRO) Charnwood Molecular, in a £54m construction project. The three-storey, state-of-the-art synthetic and chemistry research facility has been fully modernised…
The Universities of Birmingham, Leicester and Nottingham have joined forces to launch a partnership that will train the next generation of leading researchers the skills required to transform our understanding and treatment of disease. Funded by the Medical Research Council (MRC), the Advanced Inter-disciplinary Models Doctoral Training Partnership (AIM DTP) will train post-graduate students…
UK’s first megalab opens in Royal Leamington Spa – one of the centrepieces of UK’s future test and trace infrastructure. Lab will process and sequence thousands of COVID-19 tests a week and play indispensable role in responding to new variants of concern and future disease threats, while creating 1,500 skilled jobs for the area New…
Supported by Grosvenor Interiors and the dialysis unit ward staff at Addenbrooke’s Hospital, Static Systems’ Vistr Headwall® Vertical Medical Supply Unit has reached the final stages of the ‘Design Innovation for Quality Improvement’ category in the 2021 European Healthcare Design Awards. The category celebrates innovation in medical or digital technology or product design that has…
Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, has unveiled plans for significant expansion in 2021. Charnwood Molecular continues to build upon its foundation in medicinal chemistry, scale-up chemistry and custom synthesis provision, evolving its business strategy to deliver increasingly high-tech and high-value research capabilities. In order to…
The Chairman of a Leicestershire pharmaceuticals business has been selected as one of 60 international leaders and innovators to feature on a top industry influencer list. Dr Nik Kotecha OBE, who is the Founder of medicines manufacturer and supplier Morningside Pharmaceuticals, which based in Loughborough, has made The Medicine Maker magazine’s Power List 2021. The…
Pennine Healthcare, one of the UK’s leading privately-owned medical manufacturers, has handed over ownership of the company to its 200 employees to reward their loyalty and pave the way for future growth. Pennine Healthcare, which has operated in Derby for more than 50 years, has joined the growing band of forward-looking companies to set up…
Anglia Ruskin University has been recognised for the contribution it makes to life sciences, by becoming the newest Patron of Medilink Midlands. Medilink Midlands works with life science businesses, academic institutions and the NHS across the Midlands, to help new and existing life science companies to develop and grow. In addition to the business support…
The Leicester Institute of Structural and Chemical Biology (LISCB) have long-standing success in collaborating with industry in the field of drug discovery. They combine their technical capabilities in structure-based drug discovery to identify novel targets and have built expertise in chemical biology to develop next generation chemical platforms and probes. LISCB host a regular…